Hansen Gwenn sold NRIX
October 15, 2026 · Form 4 insider transaction
Hansen Gwenn sold 1,452 shares of Nurix Therapeutics, Inc. at $25.00 per share, a transaction worth $36.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,452
Price
$25.00
Total value
$36.3K
InsiderHansen Gwenn
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 15, 2026
Filing dateOctober 15, 2026
Shares owned after117,227
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.